Control of IBMIR in neonatal porcine islet xenotransplantation in baboons

American Journal of Transplantation

Volumn 14, Issue 6, 2014, Pages 1300-1309

  Hawthorne, W J ^a,b   Salvaris, E J ^c   Phillips, P ^a   Hawkes, J ^a   Liuwantara, D ^a   Burns, H ^a   Barlow, H ^c   Stewart, A B ^c   Peirce, S B ^c   Hu, M ^a   Lew, A M ^d   Robson, S C ^e   Nottle, M B ^f   D'Apice, A J F ^c   O'Connell, P J ^a,b   Cowan, P J ^c,g  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Hyperacute rejection; instant blood mediated inflammatory reaction; neonatal islet cell clusters; thrombosis; type 1 diabetes; xenotransplantation

Indexed keywords

ANTITHROMBIN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; GALACTOSYLGALACTOSE; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THROMBIN; THYMOCYTE ANTIBODY; ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BABOON; CLINICAL PROTOCOL; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DNA MODIFICATION; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HYPERACUTE GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; LIVER BIOPSY; NONHUMAN; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SWINE; THROMBOCYTE POOR PLASMA; THROMBOSIS; XENOGRAFT; XENOTRANSPLANTATION; ANIMAL; BLOOD; BOVINAE;

ANIMALS; ANTIBODIES; BLOOD; CATTLE; GRAFT REJECTION; ISLETS OF LANGERHANS TRANSPLANTATION; PAPIO; TRANSPLANTATION, HETEROLOGOUS;

EID: 84901312705     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12722     Document Type: Article

References (39)

1. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV., Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996; 97: 2119-2129. (Pubitemid 26143967)
2. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306. (Pubitemid 43355077)
3. Ekser B, Cooper DK., Overcoming the barriers to xenotransplantation: Prospects for the future. Expert Rev Clin Immunol 2010; 6: 219-230.
4. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238. (Pubitemid 30490390)
5. Bennet W, Sundberg B, Lundgren T, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: Protective effects of sCR1 and heparin. Transplantation 2000; 69: 711-719. (Pubitemid 30174086)
6. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039-2045. (Pubitemid 36026584)
7. Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B., Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: Possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002; 51: 1779-1784. (Pubitemid 34564290)
8. Spirig R, Gajanayake T, Korsgren O, Nilsson B, Rieben R., Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation. Mol Immunol 2008; 45: 4084-4094.
9. Miyagawa S, Yamamoto A, Matsunami K, et al. Complement regulation in the GalT KO era. Xenotransplantation 2010; 17: 11-25.
10. Kirchhof N, Shibata S, Wijkstrom M, et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004; 11: 396-407. (Pubitemid 39128209)
11. McKenzie IFC, Xing P-X, Sandrin MS, Koulmanda M, Mandel TE., Pig-to-human xenotransplantation: The expression of Galα(l-3)Gal epitopes on pig islet cells. Xenotransplantation 1995; 2: 1-7.
12. Rayat GR, Rajotte RV, Elliott JF, Korbutt GS., Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes 1998; 47: 1406-1411. (Pubitemid 28396943)
13. Strokan V, Bennet W, Molne J, Korsgren O, Breimer ME., Distribution of the Galalpha1-3Gal antigen in cultured adult and fetal porcine pancreatic islet cells: An immunoelectron microscopic study. Transplantation 2000; 70: 846-851.
14. Thompson P, Badell IR, Lowe M, et al. Islet xenotransplantation using Gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011; 11: 2593-2602.
15. van der Windt DJ, Bottino R, Casu A, et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009; 9: 2716-2726.
16. Cowan PJ, Aminian A, Barlow H, et al. Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transplant 2002; 2: 520-525. (Pubitemid 36306870)
17. Cowan PJ, Aminian A, Barlow H, et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504-2515. (Pubitemid 30482015)
18. Nottle MB, Beebe LF, Harrison SJ, et al. Production of homozygous alpha-1,3-galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation 2007; 14: 339-344. (Pubitemid 47174364)
19. O'Connell PJ, Holmes-Walker DJ, Goodman D, et al. Multicenter Australian trial of islet transplantation: Improving accessibility and outcomes. Am J Transplant 2013; 13: 1850-1858.
20. Hawthorne WJ, Cachia AR, Walters SN, et al. A large-animal model to evaluate the clinical potential of fetal pig pancreas fragment transplantation. Cell Transplant 2000; 9: 867-875. (Pubitemid 32102076)
21. Gock H, Murray-Segal L, Salvaris E, Cowan PJ, D'Apice AJ., Gal mismatch alone causes skin graft rejection in mice. Transplantation 2002; 74: 637-645.
22. Tu XM, Kowalski J, Zhang J, Lynch KG, Crits-Christoph P., Power analyses for longitudinal trials and other clustered designs. Stat Med 2004; 23: 2799-2815. (Pubitemid 39207203)
23. O'Connell PJ, Hawthorne WJ, Holmes-Walker DJ, et al. Clinical islet transplantation in type 1 diabetes mellitus: Results of Australia's first trial. Med J Aust 2006; 184: 221-225.
24. Shapiro AM, Lakey JR, Rajotte RV, et al. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation 1995; 59: 1060-1063.
25. Robson SC, Cooper DK, d'Apice AJ., Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000; 7: 166-176.
26. Buhler L, Deng S, O'Neil J, et al. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002; 9: 3-13. (Pubitemid 36358219)
27. Cantarovich D, Blancho G, Potiron N, et al. Rapid failure of pig islet transplantation in non human primates. Xenotransplantation 2002; 9: 25-35. (Pubitemid 36358221)
28. Thompson P, Badell IR, Lowe M, et al. Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival. Am J Transplant 2012; 12: 1765-1775.
29. Thompson P, Cardona K, Russell M, et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011; 11: 947-957.
30. Ierino FL, Kozlowski T, Siegel JB, et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998; 66: 1439-1450. (Pubitemid 29014022)
31. Esmon CT., Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004; 25: 536-542. (Pubitemid 39208352)
32. Coughlin SR., Thrombin signalling and protease-activated receptors. Nature 2000; 407: 258-264.
33. Coughlin SR, Camerer E., PARticipation in inflammation. J Clin Invest 2003; 111: 25-27. (Pubitemid 36134843)
34. Seeliger S, Derian CK, Vergnolle N, et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003; 17: 1871-1885. (Pubitemid 37214780)
35. Tokodai K, Goto M, Inagaki A, et al. Attenuation of cross-talk between the complement and coagulation cascades by C5a blockade improves early outcomes after intraportal islet transplantation. Transplantation 2010; 90: 1358-1365.
36. Kourtzelis I, Markiewski MM, Doumas M, et al. Complement anaphylotoxin C5a contributes to hemodialysis-associated thrombosis. Blood 116: 631-639.
37. McGregor CG, Ricci D, Miyagi N, et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts. Transplantation 2012; 93: 686-692.
38. Klymiuk N, van Buerck L, Bahr A, et al. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 2012; 61: 1527-1532.
39. Brady JL, Sutherland RM, Hancock M, et al. Anti-CD2 producing pig xenografts effect localized depletion of human T cells in a huSCID model. Xenotransplantation 2013; 20: 100-109.